This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
3 MS Islam & H Choi (2007) Green tea, anti-diabetic or diabetogenic: a dose response study. Biofactors 29, 45–53.
4 T Murase , A Nagasawa , J Suzuki , (2002) Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int J Obes Relat Metab Disord 26, 1459–1464.
5 S Rossner (2002) Obesity: the disease of the twenty-first century. Int J Obes Relat Metab Disord 26, Suppl. 4, S2–S4.
6 JK Lin & SY Lin-Shiau (2006) Mechanisms of hypolipidemic and anti-obesity effects of tea and tea polyphenols. Mol Nutr Food Res 50, 211–217.
8 PV Anandh Babu , KE Sabitha & CS Shyamaladevi (2006) Green tea extract impedes dyslipidaemia and development of cardiac dysfunction in streptozotocin-diabetic rats. Clin Exp Pharmacol Physiol 33, 1184–1189.
9 S Klaus , S Pultz , C Thone-Reineke , (2005) Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obes (Lond) 29, 615–623.
10 DL McKay & JB Blumberg (2007) Roles for epigallocatechin gallate in cardiovascular disease and obesity: an introduction. J Am Coll Nutr 26, 362S–365S.
11 T Yokozawa , T Nakagawa & K Kitani (2002) Antioxidative activity of green tea polyphenol in cholesterol-fed rats. J Agric Food Chem 50, 3549–3552.
12 H Chen , M Zhang & B Xie (2005) Components and antioxidant activity of polysaccharide conjugate from green tea. Food Chem 90, 17–21.
13 C Cabrera , R Artacho & R Gimenez (2006) Beneficial effects of green tea – a review. J Am Coll Nutr 25, 79–99.
14 S Wolfram (2007) Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr 26, 373S–388S.
15 ME Harbowy & DA Balentine (1997) Tea chemistry. Crit Rev Plant Sci 16, 415–448.
16 RA Riemersma , CA Rice-Evans , RM Tyrrell , (2001) Tea flavonoids and cardiovascular health. QJM 94, 277–282.
20 T Csont , G Balogh , C Csonka , (2002) Hyperlipidemia induced by high cholesterol diet inhibits heat shock response in rat hearts. Biochem Biophys Res Commun 290, 1535–1538.
21 A Onody , C Csonka , Z Giricz , (2003) Hyperlipidemia induced by a cholesterol-rich diet leads to enhanced peroxynitrite formation in rat hearts. Cardiovasc Res 58, 663–670.
22 P Trinder (1969) Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 6, 24–27.
23 CS Frings & RT Dunn (1970) A colorimetric method for determination of total serum lipids based on the sulfo-phospho-vanillin reaction. Am J Clin Pathol 53, 89–91.
24 BT Doumas , WA Watson & HG Biggs (1971) Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 31, 87–96.
26 J Vikari (1976) Precipitation of plasma lipoproteins by PEG-6000 and its evaluation with electrophoresis and ultracentrifugation. Scand J Clin Lab Invest 36, 265–268.
30 P Trinder & D Webster (1984) Determination of HDL-cholesterol using 2,4,6-tribromo-3-hydroxybenzoic acid with a commercial CHOD-PAP reagent. Ann Clin Biochem 21, 430–433.
32 S Reitman & S Frankel (1957) A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 28, 56–63.
35 JR Turner & JF Thayer (editors) (2001) Introduction to Analysis of Variance: Design, Analysis and Interpretation. Thousand Oaks, CA: Sage Publications.
38 L Czako , A Szabolcs , A Vajda , (2007) Hyperlipidemia induced by a cholesterol-rich diet aggravates necrotizing pancreatitis in rats. Eur J Pharmacol 572, 74–81.
39 J Butler , N Rodondi , Y Zhu , (2006) Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol 47, 1595–1602.
40 MW Knuiman , J Hung , ML Divitini , (2009) Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study. Eur J Cardiovasc Prev Rehabil 16, Suppl. 2, 235–241.
41 LM Thorn , C Forsblom , J Waden , (2009) Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care 32, Suppl. 5, 950–952.
42 M Shimizu , Y Kobayashi , M Suzuki , (2000) Regulation of intestinal glucose transport by tea catechins. Biofactors 13, 61–65.
43 MJ Kim , GR Ryu , JS Chung , (2003) Protective effects of epicatechin against the toxic effects of streptozotocin on rat pancreatic islets: in vivo and in vitro. Pancreas 26, 292–299.
44 EM Janle , C Portocarrero , Y Zhu , (2005) Effect of long-term oral administration of green tea extract on weight gain and glucose tolerance in Zucker diabetic (ZDF) rats. J Herb Pharmacother 5, 55–65.
45 X Zhou , D Wang , P Sun , (2007) Effects of soluble tea polysaccharides on hyperglycemia in alloxan-diabetic mice. J Agric Food Chem 55, 5523–5528.
46 ME Waltner-Law , XL Wang , BK Law , (2002) Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem 277, 34933–34940.
47 JA Chemler , LT Lock , MA Koffas , (2007) Standardized biosynthesis of flavan-3-ols with effects on pancreatic β-cell insulin secretion. Appl Microbiol Biotechnol 77, 797–807.
49 KL Kuo , MS Weng , CT Chiang , (2005) Comparative studies on the hypolipidemic and growth suppressive effects of oolong, black, pu-erh, and green tea leaves in rats. J Agric Food Chem 53, 480–489.
50 N Matsumoto , K Okushio & Y Hara (1998) Effect of black tea polyphenols on plasma lipids in cholesterol-fed rats. J Nutr Sci Vitaminol (Tokyo) 44, Suppl. 2, 337–342.
51 TT Yang & MW Koo (2000) Chinese green tea lowers cholesterol level through an increase in fecal lipid excretion. Life Sci 66, 411–423.
52 CA Bursill , M Abbey & PD Roach (2007) A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit. Atherosclerosis 193, 86–93.
53 CL Lin , HC Huang & JK Lin (2007) Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells. J Lipid Res 48, 2334–2343.
55 DG Raederstorff , MF Schlachter , V Elste , (2003) Effect of EGCG on lipid absorption and plasma lipid levels in rats. J Nutr Biochem 14, 326–332.
56 SI Koo & SK Noh (2007) Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. J Nutr Biochem 18, 179–183.
58 WL Yee , Q Wang , T Agdinaoay , (2002) Green tea catechins decrease apolipoprotein B-100 secretion from HepG2 cells. Mol Cell Biochem 229, 85–92.
59 DA Balentine , SA Wiseman & LC Bouwens (1997) The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 37, 693–704.
62 EB Taylor , WJ Ellingson , JD Lamb , (2005) Long-chain acyl-CoA esters inhibit phosphorylation of AMP-activated protein kinase at threonine-172 by LKB1/STRAD/MO25. Am J Physiol Endocrinol Metab 288, E1055–E1061.
63 T Murase , K Misawa , S Haramizu , (2009) Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway. Biochem Pharmacol 78, 78–84.
64 CL Lin & JK Lin (2008) Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells. Mol Nutr Food Res 52, 930–939.
65 VE Steele , GJ Kelloff , D Balentine , (2000) Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays. Carcinogenesis 21, 63–67.